期刊文献+

胃肠道细菌性感染的治疗 被引量:5

原文传递
导出
摘要 胃肠道细菌性感染的治疗姜素椿胃肠道是人体内最长的管道,长9米,是病毒性肝炎、脊髓灰质炎及多数败血症病原的入侵场所,并且在各段管腔有各种常见易感病原,如近年所认识的幽门螺杆菌(Hp)是胃及十二指肠溃疡、非溃疡性炎症相关的细菌,虽然其发病机制尚未完全清楚...
作者 姜素椿
机构地区 解放军
出处 《中华内科杂志》 CAS CSCD 北大核心 1997年第3期212-214,共3页 Chinese Journal of Internal Medicine
  • 相关文献

同被引文献11

  • 1朱汝锦.磷霉素三羟甲基氨基甲烷[J].国外医药(抗生素分册),1996,17(2):110-113. 被引量:5
  • 2丁建强.志贺氏菌属感染若干方面的研究进展[J].国外医学(流行病学.传染病学分册),1997,24(2):56-60. 被引量:17
  • 3孙殿兴,张福广,耿云琴,齐建民,米润昭,李东,李仕英,张红,侯天文.细菌性痢疾菌型及耐药性分析[J].中国实用内科杂志,1997,17(3):150-152. 被引量:20
  • 4柴文清 衣淑珍.利福昔明[J].国外医学:药学分册,1995,(5):308-308.
  • 5Ashkenazi S, May- Zahav M, Sulkes Jet al. Increasing antimicrobial resistance of shigella isolates in Israel during the period 1984 to 1992[J]. Antimicrob Agents Chemother, 1995; 39(4) :819-823.
  • 6Mas A, Rodes T, Sunyer L, et al. Comparison of rifaximin andlactitol in the treatment ofacute hepatic encephalopathy. results of a randomized, double - blind, double - dummy, controlledclinical trial[J]. J Hepatol,2003,38 ( 1 ) :51 - 58.
  • 7Ashkenazi S, May - Zahav M, Sulkes Jet al. Increasing antimicrobi al resistance of shigellaisolates in Israel during the period 1984 to 1992 [ J]. Antimicrob Agents Chemother, 1995,39(4) :819 - 823.
  • 8DuPont HL,Jiang ZD, Ericsson CD,et al. Rifaximin Versus eiprofloxaein for the treatmentof traveler's diarhoea: a randomized, double - blind clinical trial [ J ]. Olin Infect Dis, 2001,33( 11 ) :1807 - 1815.
  • 9Jiang ZD, Ke S, Pal azzini E, et al. In vitro activity andfecal concentra- tion of rifaximin afteroral administration [ J ]. Antimicrob Agents Chemother, 2000,44 ( 8 ) :2205 - 2206.
  • 10Ashkenazi S, May- Zahav M, Sulkes J et al. Increasing antimicrobial resistance of shigella isolates in Israel during the period 1984 to 1992[J]. Antimicrob Agents Chemother, 1995,39(4) :819 - 823.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部